Immunomodulatory properties of Brucella melitensis lipopolysaccharide determinants on mouse dendritic cells in vitro and in vivo

References

• Dean AS, Crump L, Greter H, Schelling E, Zinsstag J. Global burden of human brucellosis: A systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6. doi:10.1371/journal.pntd.0001865. PMID:23145195
   PubMed Web of Science ®Google Scholar
• Gorvel JP, Moreno E. Brucella intracellular life: From invasion to intracellular replication. Vet Microbiol. 2002;90:281–97. doi:10.1016/S0378-1135(02)00214-6. PMID:12414149
   PubMed Web of Science ®Google Scholar
• Gorvel JP. “If you bring an alarm, we will destroy it,” said Brucella to the host cell. Virulence. 2014;5:460–2. doi:10.4161/viru.29092. PMID:24786767
   PubMed Web of Science ®Google Scholar
• Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzman-Verri C, Chacon-Diaz C, Rucavado A, Moriyón I, Moreno E. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One. 2007;2. doi:10.1371/journal.pone.0000631. PMID:17637846
   PubMed Web of Science ®Google Scholar
• Celli J. Surviving inside a macrophage: The many ways of Brucella. Res Microbiol. 2006;157:93–8. doi:10.1016/j.resmic.2005.10.002. PMID:16364608
   PubMed Web of Science ®Google Scholar
• Erridge C, Bennett-Guerrero E, Poxton IR. Structure and function of lipopolysaccharides. Microbes Infect. 2002;4:837–51. doi:10.1016/S1286-4579(02)01604-0. PMID:12270731
   PubMed Web of Science ®Google Scholar
• Cardoso PG, Macedo GC, Azevedo V, Oliveira SC. Brucella spp noncanonical LPS: Structure, biosynthesis, and interaction with host immune system. Microb Cell Fact. 2006;5:13. doi:10.1186/1475-2859-5-S1-S13 10.1186/1475-2859-5-S1-P13 10.1186/1475-2859-5-13. PMID:16556309
   PubMed Web of Science ®Google Scholar
• Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151–61. doi:10.1038/nri746. PMID:11913066
   PubMed Web of Science ®Google Scholar
• Hey YY, O'Neill HC. Murine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function. J Cell Mol Med. 2012;16:2611–9. doi:10.1111/j.1582-4934.2012.01608.x. PMID:22862733
   PubMed Web of Science ®Google Scholar
• Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, Lahoud MH, O'Keeffe M, Shao QX, Chen WF, et al. Cutting edge: Generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol. 2005;174:6592–7. doi:10.4049/jimmunol.174.11.6592. PMID:15905497
   PubMed Web of Science ®Google Scholar
• Naik SH, Sathe P, Park HY, Metcalf D, Proietto AI, Dakic A, Carotta S, O'Keeffe M, Bahlo M, Papenfuss A, et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol. 2007;8:1217–26. doi:10.1038/ni1522. PMID:17922015
   PubMed Web of Science ®Google Scholar
• Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev. 2010;234:142–62. doi:10.1111/j.0105-2896.2009.00881.x. PMID:20193017
   PubMed Web of Science ®Google Scholar
• Behboudi S, Moore A, Hill AVS. Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells. Cell Immunol. 2004;228:15–9. doi:10.1016/j.cellimm.2004.03.010. PMID:15203315
   PubMed Web of Science ®Google Scholar
• Leon B, Ardavin C. Monocyte-derived dendritic cells in innate and adaptive immunity. Immunol Cell Biol. 2008;86:320–4. doi:10.1038/icb.2008.14. PMID:18362945
   PubMed Web of Science ®Google Scholar
• Qu CF, Brinck-Jensen NS, Zang MY, Chen K. Monocyte-derived dendritic cells: Targets as potent antigen-presenting cells for the design of vaccines against infectious diseases. Int J Infect Dis. 2014;19:1–5. doi:10.1016/j.ijid.2013.09.023. PMID:24216295
   PubMed Web of Science ®Google Scholar
• Langlet C, Tamoutounour S, Henri S, Luche H, Ardouin L, Gregoire C, Malissen B, Guilliams M. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J Immunol. 2012;188:1751–60. doi:10.4049/jimmunol.1102744. PMID:22262658
   PubMed Web of Science ®Google Scholar
• Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco-Madeira F, Toussaint W, Vanhoutte L, Neyt K, Killeen N, Malissen B, et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity. 2013;38:322–35. doi:10.1016/j.immuni.2012.10.016. PMID:23352232
   PubMed Web of Science ®Google Scholar
• Cheong C, Matos I, Choi JH, Dandamudi DB, Shrestha E, Longhi MP, Jeffrey KL, Anthony RM, Kluger C, Nchinda G, et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell. 2010;143:416–29. doi:10.1016/j.cell.2010.09.039. PMID:21029863
   PubMed Web of Science ®Google Scholar
• Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone-marrow cultures supplemented with granulocyte macrophage colony-stimulating factor. J Exp Med. 1992;176:1693–702. doi:10.1084/jem.176.6.1693. PMID:1460426
   PubMed Web of Science ®Google Scholar
• Weigel BJ, Nath N, Taylor PA, Panoskaltsis-Mortari A, Chen W, Krieg AM, Brasel K, Blazar BR. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses. Blood. 2002;100:4169–76. doi:10.1182/blood-2002-04-1063. PMID:12393694
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol. 2007;179:7577–84. doi:10.4049/jimmunol.179.11.7577. PMID:18025203
   PubMed Web of Science ®Google Scholar
• Conde-Alvarez R, Arce-Gorvel V, Iriarte M, Mancek-Keber M, Barquero-Calvo E, Palacios-Chaves L, Chacón-Díaz C, Chaves-Olarte E, Martirosyan A, von Bargen K, et al. The lipopolysaccharide core of brucella abortus acts as a shield against innate immunity recognition. PLoS Pathog. 2012;8. doi:10.1371/journal.ppat.1002675. PMID:22589715
   PubMed Web of Science ®Google Scholar
• Fontana C, Conde-Alvarez R, Stahle J, Holst O, Iriarte M, Zhao Y, Arce-Gorvel V, Hanniffy S, Gorvel JP, Moriyón I, et al. Structural studies of lipopolysaccharide-defective mutants from brucella melitensis identify a core oligosaccharide critical in virulence. J Biol Chem. 2016;291:7727–41. doi:10.1074/jbc.M115.701540. PMID:26867577
   PubMed Web of Science ®Google Scholar
• Papadopoulos A, Gagnaire A, Degos C, de Chastellier C, Gorvel JP. Brucella discriminates between mouse dendritic cell subsets upon in vitro infection. Virulence. 2016;7:33–44. doi:10.1080/21505594.2015.1108516. PMID:26606688
   PubMed Web of Science ®Google Scholar
• Gil-Ramirez Y, Conde-Alvarez R, Palacios-Chaves L, Zuniga-Ripa A, Grillo MJ, Arce-Gorvel V, Hanniffy S, Moriyón I, Iriarte M. The identification of wadB, a new glycosyltransferase gene, confirms the branched structure and the role in virulence of the lipopolysaccharide core of Brucella abortus. Microb Pathog. 2014;73:53–9. doi:10.1016/j.micpath.2014.06.002. PMID:24927935
   PubMed Web of Science ®Google Scholar
• Barquero-Calvo E, Conde-Alvarez R, Chacon-Diaz C, Quesada-Lobo L, Martirosyan A, Guzman-Verri C, Iriarte M, Mancek-Keber M, Jerala R, Gorvel JP, et al. The differential interaction of Brucella and Ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens. PLoS One. 2009;4. doi:10.1371/journal.pone.0005893. PMID:19529776
   PubMed Web of Science ®Google Scholar
• Velasco J, Bengoechea JA, Brandenburg K, Lindner B, Seydel U, Gonzalez D, Zähringer U, Moreno E, Moriyón I. Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun. 2000;68:3210–8. doi:10.1128/IAI.68.6.3210-3218.2000. PMID:10816465
   PubMed Web of Science ®Google Scholar
• Velasco J, Moll H, Knirel YA, Sinnwell V, Moriyon I, Zahringer U. Structural studies on the lipopolysaccharide from a rough strain of Ochrobactrum anthropi containing a 2,3-diamino-2,3-dideoxy-D-glucose disaccharide lipid A backbone. Carbohydr Res. 1998;306:283–90. doi:10.1016/S0008-6215(97)10029-5. PMID:9691452
   PubMed Web of Science ®Google Scholar
• Goldstein J, Hoffman T, Frasch C, Lizzio EF, Beining PR, Hochstein D, Lee YL, Angus RD, Golding B. Lipopolysaccharide (Lps) from Brucella-abortus is less toxic than that from Escherichia-coli, suggesting the possible use of B-abortus or Lps from B-abortus as a carrier in vaccines. Infect Immun. 1992;60:1385–9. PMID:1548064
   PubMed Web of Science ®Google Scholar
• Lapaque N, Moriyon I, Moreno E, Gorvel JP. Brucella lipopolysaccharide acts as a virulence factor. Curr Opin Microbiol. 2005;8:60–6. doi:10.1016/j.mib.2004.12.003. PMID:15694858
   PubMed Web of Science ®Google Scholar
• Martirosyan A, Moreno E, Gorvel JP. An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol Rev. 2011;240:211–34. doi:10.1111/j.1600-065X.2010.00982.x. PMID:21349096
   PubMed Web of Science ®Google Scholar
• Jamalan M, Ardestani SK, Zeinali M, Mosaveri N, Mohammad Taheri M. Effectiveness of Brucella abortus lipopolysaccharide as an adjuvant for tuberculin PPD. Biologicals. 2011;39:23–8. doi:10.1016/j.biologicals.2010.08.005. PMID:20965746
   PubMed Web of Science ®Google Scholar
• Kianmehr Z, Soleimanjahi H, Ardestani SK, Fotouhi F, Abdoli A. Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice. Med Microbiol Immunol. 2015;204:205–13. doi:10.1007/s00430-014-0356-z. PMID:25187406
   PubMed Web of Science ®Google Scholar
• Moreno E, Kurtz RS, Berman DT. Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide. Infect Immun. 1984;46:74–80. PMID:6434430
   PubMed Web of Science ®Google Scholar
• Conde-Alvarez R, Arce-Gorvel V, Gil-Ramirez Y, Iriarte M, Grillo MJ, Gorvel JP, Moriyón I. Lipopolysaccharide as a target for brucellosis vaccine design. Microb Pathog. 2013;58:29–34. doi:10.1016/j.micpath.2012.11.011. PMID:23219811
   PubMed Web of Science ®Google Scholar
• Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grünig G, Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995;96:2339–47. doi:10.1172/JCI118290. PMID:7593621
   PubMed Web of Science ®Google Scholar
• Vaure C, Liu Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol. 2014;5:316. doi:10.3389/fimmu.2014.00316. PMID:25071777
   PubMed Web of Science ®Google Scholar
• Ahmed K, Al-Matrouk KA, Martinez G, Oishi K, Rotimi VO, Nagatake T. Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. Am J Trop Med Hyg. 1999;61:425–7. doi:10.4269/ajtmh.1999.61.425. PMID:10497984
   PubMed Web of Science ®Google Scholar
• Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: Does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol. 2006;26:407–42. doi:10.1615/CritRevImmunol.v26.i5.30. PMID:17341186
   PubMed Web of Science ®Google Scholar
• Zhan Y, Cheers C. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect Immun. 1995;63:1387–90. PMID:7890399
   PubMed Web of Science ®Google Scholar
• Macedo GC, Magnani DM, Carvalho NB, Bruna-Romero O, Gazzinelli RT, Oliveira SC. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J Immunol. 2008;180:1080–7. doi:10.4049/jimmunol.180.2.1080. PMID:18178848
   PubMed Web of Science ®Google Scholar
• Brandao AP, Oliveira FS, Carvalho NB, Vieira LQ, Azevedo V, Macedo GC, Oliveira SC. Host susceptibility to Brucella abortus infection is more pronounced in IFN-gamma knockout than IL-12/beta2-microglobulin double-deficient mice. Clin Dev Immunol. 2012;2012:589494. doi:10.1155/2012/589494. PMID:22194770
   PubMedGoogle Scholar
• Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA, Davey GM, Wilson NS, Carbone FR, Villadangos JA. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev. 2004;199:9–26. doi:10.1111/j.0105-2896.2004.00142.x. PMID:15233723
   PubMed Web of Science ®Google Scholar
• Naik SH. Demystifying the development of dendritic cell subtypes, a little. Immunol Cell Biol. 2008;86:439–52. doi:10.1038/icb.2008.28. PMID:18414430
   PubMed Web of Science ®Google Scholar
• Guilliams M, Bruhns P, Saeys Y, Hammad H, Lambrecht BN. The function of Fcgamma receptors in dendritic cells and macrophages. Nat Rev Immunol. 2014;14:94–108. doi:10.1038/nri3582 10.1038/nri3666. PMID:24445665
   PubMed Web of Science ®Google Scholar
• Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol. 1999;162:3749–52. PMID:10201887
   PubMed Web of Science ®Google Scholar
• Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol. 2000;165:618–22. doi:10.4049/jimmunol.165.2.618. PMID:10878331
   PubMed Web of Science ®Google Scholar
• Lapaque N, Takeuchi O, Corrales F, Akira S, Moriyon I, Howard JC, Gorvel JP. Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides. Cell Microbiol. 2006;8:401–13. doi:10.1111/j.1462-5822.2005.00629.x. PMID:16469053
   PubMed Web of Science ®Google Scholar
• Martirosyan A, Ohne Y, Degos C, Gorvel L, Moriyon I, Oh S, Gorvel JP. Lipopolysaccharides with acylation defects potentiate TLR4 signaling and shape T cell responses. PLoS One. 2013;8:e55117. doi:10.1371/journal.pone.0055117. PMID:23390517
   PubMed Web of Science ®Google Scholar